THURSDAY, Aug. 19 (HealthDay News) -- Use of the drug trastuzumab in addition to chemotherapy can extend stomach cancer patients' survival by nearly three months, a new study has found. However, an editorial accompanying the study questions whethe...
via Healthline News : RSS Read More Here..
via Healthline News : RSS Read More Here..
No comments:
Post a Comment